ID

36593

Beskrivning

Theranostic Tool During Erlotinib Treatment in Non-small Cell Lung Cancer Patient; ODM derived from: https://clinicaltrials.gov/show/NCT02069418

Länk

https://clinicaltrials.gov/show/NCT02069418

Nyckelord

Versioner (1)
  1. 2019-05-24 2019-05-24 -
Rättsinnehavare

See clinicaltrials.gov

Uppladdad den

24 maj 2019

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Non-small Cell Lung Cancer Metastatic or Non-small Cell Lung Cancer Recurrent NCT02069418

Engelsk

Eligibility Non-small Cell Lung Cancer Metastatic or Non-small Cell Lung Cancer Recurrent NCT02069418

1 Formulär  
Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
age over superior to 18
Beskrivning

Age

Datatyp

boolean

Alias
UMLS CUI [1]
C0001779
nsclc proved by a histological biopsy
Beskrivning

Non-Small Cell Lung Carcinoma

Datatyp

boolean

Alias
UMLS CUI [1]
C0007131
egfr mutation status known with no activating egfr mutation
Beskrivning

EGFR gene mutation Status Known | EGFR Activating Mutation Absent

Datatyp

boolean

Alias
UMLS CUI [1,1]
C3266992
UMLS CUI [1,2]
C0449438
UMLS CUI [1,3]
C0205309
UMLS CUI [2,1]
C2984891
UMLS CUI [2,2]
C0332197
indication of erlotinib therapy after at least one previous therapy
Beskrivning

Indication Erlotinib | Status post Prior Therapy Quantity

Datatyp

boolean

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C1135135
UMLS CUI [2,1]
C0231290
UMLS CUI [2,2]
C1514463
UMLS CUI [2,3]
C1265611
patients who have signed an informed consent to participate in this study
Beskrivning

Informed Consent

Datatyp

boolean

Alias
UMLS CUI [1]
C0021430
life expectancy exceeding 12 weeks
Beskrivning

Life Expectancy

Datatyp

boolean

Alias
UMLS CUI [1]
C0023671
who activity score between 0 and 2.
Beskrivning

WHO Physical activity score

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0043237
UMLS CUI [1,2]
C4482422
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
contraindication for the initiation of erlotinib
Beskrivning

Medical contraindication Erlotinib

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C1135135
refusal to sign the consent
Beskrivning

Informed Consent Refused

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C1705116
progressive inflammatory disease
Beskrivning

Inflammatory disorder Progressive

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1290884
UMLS CUI [1,2]
C0205329
infection with the hiv virus
Beskrivning

HIV Infection

Datatyp

boolean

Alias
UMLS CUI [1]
C0019693
other malignant disease
Beskrivning

Malignant disease Other

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0442867
UMLS CUI [1,2]
C0205394
life expectancy less than 12 weeks
Beskrivning

Life Expectancy

Datatyp

boolean

Alias
UMLS CUI [1]
C0023671
major adults protected by french law
Beskrivning

Adult Protection Law France

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0001675
UMLS CUI [1,2]
C0412786
UMLS CUI [1,3]
C0220866
UMLS CUI [1,4]
C0016674
Tillbaka till toppen

Similar models

Eligibility Non-small Cell Lung Cancer Metastatic or Non-small Cell Lung Cancer Recurrent NCT02069418

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age over superior to 18
boolean
C0001779 (UMLS CUI [1])
Non-Small Cell Lung Carcinoma
Item
nsclc proved by a histological biopsy
boolean
C0007131 (UMLS CUI [1])
EGFR gene mutation Status Known | EGFR Activating Mutation Absent
Item
egfr mutation status known with no activating egfr mutation
boolean
C3266992 (UMLS CUI [1,1])
C0449438 (UMLS CUI [1,2])
C0205309 (UMLS CUI [1,3])
C2984891 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Indication Erlotinib | Status post Prior Therapy Quantity
Item
indication of erlotinib therapy after at least one previous therapy
boolean
C3146298 (UMLS CUI [1,1])
C1135135 (UMLS CUI [1,2])
C0231290 (UMLS CUI [2,1])
C1514463 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
Informed Consent
Item
patients who have signed an informed consent to participate in this study
boolean
C0021430 (UMLS CUI [1])
Life Expectancy
Item
life expectancy exceeding 12 weeks
boolean
C0023671 (UMLS CUI [1])
WHO Physical activity score
Item
who activity score between 0 and 2.
boolean
C0043237 (UMLS CUI [1,1])
C4482422 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Medical contraindication Erlotinib
Item
contraindication for the initiation of erlotinib
boolean
C1301624 (UMLS CUI [1,1])
C1135135 (UMLS CUI [1,2])
Informed Consent Refused
Item
refusal to sign the consent
boolean
C0021430 (UMLS CUI [1,1])
C1705116 (UMLS CUI [1,2])
Inflammatory disorder Progressive
Item
progressive inflammatory disease
boolean
C1290884 (UMLS CUI [1,1])
C0205329 (UMLS CUI [1,2])
HIV Infection
Item
infection with the hiv virus
boolean
C0019693 (UMLS CUI [1])
Malignant disease Other
Item
other malignant disease
boolean
C0442867 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Life Expectancy
Item
life expectancy less than 12 weeks
boolean
C0023671 (UMLS CUI [1])
Adult Protection Law France
Item
major adults protected by french law
boolean
C0001675 (UMLS CUI [1,1])
C0412786 (UMLS CUI [1,2])
C0220866 (UMLS CUI [1,3])
C0016674 (UMLS CUI [1,4])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial